BioPhoenix brings together seasoned leaders and experts across drug discovery, clinical development, regulatory strategy, and global commercialization. Through their scientific, clinical, and industry expertise, our advisors provide strategic guidance to support BioPhoenix's research and development, pipeline advancement, and long-term growth.
Scientific Advisory Board
-
Chi-Ying F. Huang, Ph.D.
National Yang Ming
Chiao Tung UniversityDistinguished Professor & Dean
-
Ming-Tain Lai, Ph.D.
OBI Pharma
Former Chief Scientific Officer
-
Stan Lin, Ph.D.
CHO Pharmaceutical
Former Executive Vice President
-
Jacqueline Ming Liu, M.D.
BioDLink International
Former Chief Medical Officer
-
D. Mark McClung
Sangamo Therapeutics
Former Executive Vice President & Chief Operating Officer
-
Ping-Yang Yeh, Ph.D.
NovaRadar Bio Venture
Managing Partner